<VariationArchive RecordType="classified" VariationID="1683496" VariationName="NM_003221.4(TFAP2B):c.602-5_606del" VariationType="Deletion" Accession="VCV001683496" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-07-02" MostRecentSubmission="2022-07-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1675428" VariationID="1683496">
      <GeneList>
        <Gene Symbol="TFAP2B" FullName="transcription factor AP-2 beta" GeneID="7021" HGNC_ID="HGNC:11743" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="50818355" stop="50847619" display_start="50818355" display_stop="50847619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="50786438" stop="50815325" display_start="50786438" display_stop="50815325" Strand="+" />
          </Location>
          <OMIM>601601</OMIM>
          <Haploinsufficiency last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TFAP2B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TFAP2B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003221.4(TFAP2B):c.602-5_606del</Name>
      <CanonicalSPDI>NC_000006.12:50836055:TCTAGTTCCA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="50836056" stop="50836065" display_start="50836056" display_stop="50836065" variantLength="10" positionVCF="50836055" referenceAlleleVCF="TTCTAGTTCCA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.50836056_50836065del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.50836056_50836065del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008438.1" sequenceAccession="NG_008438" sequenceVersion="1" change="g.22331_22340del">
            <Expression>NG_008438.1:g.22331_22340del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003221.4" sequenceAccession="NM_003221" sequenceVersion="4" change="c.602-5_606del" MANESelect="true">
            <Expression>NM_003221.4:c.602-5_606del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003221.4" sequenceAccession="NM_003221" sequenceVersion="4" change="c.602-5_606delTCTAGTTCCA" MANESelect="true">
            <Expression>NM_003221.4:c.602-5_606delTCTAGTTCCA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2113949539" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="effect on RNA splicing">
        <XRef ID="0362" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003221.4(TFAP2B):c.602-5_606del AND Chronic intestinal pseudoobstruction" Accession="RCV002259412" Version="1">
        <ClassifiedConditionList TraitSetID="23251">
          <ClassifiedCondition DB="MedGen" ID="C0238062">Chronic intestinal pseudoobstruction</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-07-02" MostRecentSubmission="2022-07-02">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="23251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34407" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chronic intestinal pseudoobstruction</ElementValue>
                <XRef ID="MONDO:0017574" DB="MONDO" />
                <XRef ID="2978" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12744" />
                <XRef ID="12744" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2978" DB="Orphanet" />
              <XRef ID="C0238062" DB="MedGen" />
              <XRef ID="MONDO:0017574" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4923964" SubmissionDate="2022-05-13" DateLastUpdated="2022-07-02" DateCreated="2022-07-02">
        <ClinVarSubmissionID localKey="SUB11463804" submittedAssembly="GRCh37" title="SUB11463804" />
        <ClinVarAccession Accession="SCV002507296" DateUpdated="2022-07-02" DateCreated="2022-07-02" Type="SCV" Version="1" SubmitterName="Clinical Genetics, Erasmus University Medical Center" OrgID="505701" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>HiseqNovaseq 6000</NamePlatform>
              <TypePlatform>High-Throughput DNA Sequencing</TypePlatform>
              <Description>Three micrograms of dsDNA was fragmented (Covaris) and exonic sequences were captured using the Agilent SureSelect Clinical Research Exome V2. Paired-end sequencing on a Novaseq 6000 with a paired-end 2x101bp protocol and an average coverage of 50X. Reads were mapped against the human reference genome GRCh37/hg19 with the Burrows-Wheeler Aligner [1], variants were called using the Genome Analysis Toolkit. Alissa Interpret software was used to filter and prioritize variants</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>in vitro</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">splicing affected</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Comment>using a mini gene assay splicing was evaluated</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TFAP2B">
              <Name>transcription factor AP-2 beta</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_003221.4:intron 3</GeneLocation>
          </Location>
          <FunctionalConsequence Value="effect on RNA splicing">
            <XRef DB="Variation Ontology" ID="0362" URL="http://purl.obolibrary.org/obo/VariO_0362" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003221.4:c.602-5_606delTCTAGTTCCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA2978" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11463804</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4923964" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA2978" MappingRef="Orphanet">
        <MedGen CUI="C0238062" Name="Chronic intestinal pseudoobstruction" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

